Since AA restriction upregulates ATF4 in activated T cells (Fig. 1E) and TRIB3 overexpression is consistently observed across various cancers (Supplementary Fig. 3A), we employed the 2xAARE system from the TRIB3 gene to create an ATF4-based strategy that restricts CAR expression to the TME. The gene discussed is ATF4; the disease is cancer.